Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 38

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Skin grafting and tissue replacement for treating foot ulcers in people with diabetes

Santema, Trientje B, Poyck, Paul PC, Ubbink, Dirk T·2016·Cochrane Database of Systematic Reviews
DOI 10.1002/14651858.cd011255.pub2
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd011255.pub2

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 74

  1. Brigido, 2006, The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study, International Wound Journal, 3, 181, 10.1111/j.1742-481X.2006.00209.x · DOI
  2. Caravaggi, 2003, HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial, Diabetes Care, 26, 2853, 10.2337/diacare.26.10.2853 · DOI
  3. DiDomenico, 2011, A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute, Wounds, 23, 184
  4. Edmonds, 2009, Apligraf in the treatment of neuropathic diabetic foot ulcers, The International Journal of Lower Extremity Wounds, 8, 11, 10.1177/1534734609331597 · DOI
  5. Gentzkow, 1996, Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers, Diabetes Care, 19, 350, 10.2337/diacare.19.4.350 · DOI
  6. Gilligan, 2015, Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products, Journal of Wound Care, 23, 149, 10.12968/jowc.2015.24.3.149 · DOI
  7. Landsman, 2008, Living cells or collegen matrix: which is more beneficial in the treatment of diabetic foot ulcers, Wounds, 20, 111
  8. Lipkin, 2003, Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers, Wounds, 15, 230
  9. Frykberg, 2015, The incidence of lower-extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast-derived dermal substitute, Advances in Skin & Wound Care, 28, 17, 10.1097/01.ASW.0000456630.12766.e9 · DOI
  10. Marston, 2003, The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial, Diabetes Care, 26, 1701, 10.2337/diacare.26.6.1701 · DOI · Paper page
  11. Naughton, 1997, A metabolically active human dermal replacement for the treatment of diabetic foot ulcer, Artificial Organs, 21, 1203, 10.1111/j.1525-1594.1997.tb00476.x · DOI
  12. Pollak, 1997, A human dermal replacement for the treatment of diabetic foot ulcers, Wounds, 9, 175
  13. Puttirutvong, 2004, Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage, Journal of the Medical Association of Thailand, 87, 66
  14. Reyzelman, 2009, Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study, International Wound Journal, 6, 196, 10.1111/j.1742-481X.2009.00585.x · DOI · Paper page
  15. Sanders, 2014, A prospective, multicenter, randomized, controlled clinical trial comparing a bioengineered skin substitute to a human skin allograft, Ostomy Wound Management, 60, 26
  16. Uccioli, 2011, Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up, The International Journal of Lower Extremity Wounds, 10, 80, 10.1177/1534734611409371 · DOI
  17. Veves, 2001, Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial, Diabetes Care, 24, 290, 10.2337/diacare.24.2.290 · DOI · Paper page
  18. You, 2012, Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes--a pilot study, Wound Repair and Regeneration, 20, 491, 10.1111/j.1524-475X.2012.00809.x · DOI
  19. You, 2014, Randomised controlled clinical trial for autologous fibroblast-hyaluronic acid complex in treating diabetic foot ulcers, Journal of Wound Care, 23, 521, 10.12968/jowc.2014.23.11.521 · DOI
  20. Zelen, 2013, A prospective, randomised comparative parallel study amniotic membrane wound graft in the management of diabetic foot ulcers, International Wound Journal, 10, 502, 10.1111/iwj.12097 · DOI
  21. Hanft, 2002, Healing of chronic foot ulcer in diabetic patients treated with a human fibroblast-derived dermis, The Journal of Foot & Ankle Surgery, 41, 291, 10.1016/S1067-2516(02)80047-3 · DOI
  22. Moustafa, 2007, Randomized, controlled, single-blind study on use of autologous keratinocytes on a transfer dressing to treat nonhealing diabetic ulcers, Regenerative medicine, 2, 887, 10.2217/17460751.2.6.887 · DOI
  23. Niezgoda, 2005, Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers, Advances in Skin & Wound Care, 18, 258, 10.1097/00129334-200506000-00012 · DOI
  24. Pham, 1999, Evaluation of a human skin equivalent for the treatment of diabetic foot ulcers in a prospective, randomized, clinical trial, Wounds, 11, 1044
  25. Sams, 2002, Graftskin treatment of difficult to heal diabetic foot ulcers: one center's experience, Dermatologic Surgery, 28, 698
  26. Lavery, 2014, The efficacy and safety of Grafix® for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial, International Wound Journal, 11, 554, 10.1111/iwj.12329 · DOI · Paper page
  27. Abbott, 2005, Foot ulcer risk is lower in South Asian and African-Caribbean compared to European diabetic patients in the UK: the North-West Diabetes Footcare Study, Diabetes Care, 28, 1869–75, 10.2337/diacare.28.8.1869 · DOI
  28. Apelqvist, 1995, Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting, Foot & Ankle International, 16, 388, 10.1177/107110079501600702 · DOI
  29. Apelqvist, 1999, What is the most effective way to reduce incidence of amputation in the diabetic foot?, Diabetes/Metabolism Research and Reviews, 16 Suppl 1, 75
  30. Bergin, 2006, Silver based wound dressings and topical agents for treating diabetic foot ulcers, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005082.pub2 · DOI
  31. Blozik, 2008, Skin replacement therapies for diabetic foot ulcers: systematic review and meta-analysis, Diabetes Care, 41, 693, 10.2337/dc07-2081 · DOI
  32. Boulton, 2008, The diabetic foot: grand overview, epidemiology and pathogenesis, Diabetes/Metabolism Research and Reviews, 24 Suppl 1, 3, 10.1002/dmrr.833 · DOI · Paper page
  33. Cruciani, 2013, Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD006810.pub3 · DOI
  34. Danaei, 2011, National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants, The Lancet, 378, 31, 10.1016/S0140-6736(11)60679-X · DOI · Paper page
  35. Dumville, 2013, Alginate dressings for healing diabetic foot ulcers, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD009110.pub3 · DOI
  36. Dumville, 2013, Foam dressings for healing diabetic foot ulcers, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD009111.pub3 · DOI
  37. Dumville, 2013, Hydrogel dressings for healing diabetic foot ulcers, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD009101.pub3 · DOI
  38. Dumville, 2013, Hydrocolloid dressings for healing diabetic foot ulcers, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD009099.pub3 · DOI
  39. Edwards, 2010, Debridement of diabetic foot ulcers, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003556.pub2 · DOI
  40. Falanga, 1998, Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent, Archives of Dermatology, 134, 293, 10.1001/archderm.134.3.293 · DOI
  41. Falanga, 2005, Wound healing and its impairment in the diabetic foot, Lancet, 366, 1736, 10.1016/S0140-6736(05)67700-8 · DOI
  42. Fernando, 2013, Intensive versus conventional glycaemic control for treating diabetic foot ulcers, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD010764 · DOI
  43. Frykberg, 2015, The incidence of lower-extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast-derived dermal substitute, Advances in Skin & Wound Care, 28, 17, 10.1097/01.ASW.0000456630.12766.e9 · DOI
  44. Game, 2012, Choosing life or limb. Improving survival in the multi-complex diabetic foot patient, Diabetes/Metabolism Research and Reviews, 28 Suppl 1, 97, 10.1002/dmrr.2244 · DOI
  45. Gilligan, 2015, Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products, Journal of Wound Care, 24, 149, 10.12968/jowc.2015.24.3.149 · DOI
  46. Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
  47. Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org
  48. Hinchliffe, 2012, A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease, Diabetes/Metabolism Research and Reviews, 28 Suppl 1, 179, 10.1002/dmrr.2249 · DOI
  49. Izumi, 2009, Mortality of first-time amputees in diabetics: a 10-year observation, Diabetes Research and Clinical Practice, 83, 126, 10.1016/j.diabres.2008.09.005 · DOI
  50. Jeffcoate, 2003, Diabetic foot ulcers, The Lancet, 261, 1545, 10.1016/S0140-6736(03)13169-8 · DOI · Paper page
  51. Jeffcoate, 2004, Amputation as a marker of the quality of foot care in diabetes, Diabetologia, 47, 2051, 10.1007/s00125-004-1584-3 · DOI
  52. Jull, 2013, Honey as a topical treatment for wounds, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005083.pub3 · DOI
  53. Kranke, 2015, Hyperbaric oxygen therapy for chronic wounds, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD004123.pub3 · DOI
  54. Langer, 2009, Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers, BMC Health Services Research, 9, 115, 10.1186/1472-6963-9-115 · DOI
  55. Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org
  56. Levin, 1998, Prevention and treatment of diabetic foot ulcers, Journal of Wound Ostomy and Continence Nursing, 21, 129
  57. Lewis, 2013, Pressure-relieving interventions for treating diabetic foot ulcers, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD002302.pub2 · DOI
  58. Margolis, 1999, Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis, Diabetes Care, 22, 692, 10.2337/diacare.22.5.692 · DOI · Paper page
  59. Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement, BMJ, 339, 2535, 10.1136/bmj.b2535 · DOI · Paper page
  60. Nabuurs-Franssen, 2005, Health-related quality of life of diabetic foot ulcer patients and their caregivers, Diabetologia, 48, 1906, 10.1007/s00125-005-1856-6 · DOI · Paper page
  61. Pham, 2000, Wound healing in diabetic foot ulceration. A review and commentary, Wounds, 12, 79
  62. Quattrini, 2008, Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy, Diabetes Care, 31, 140, 10.2337/dc07-1556 · DOI
  63. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014
  64. Schaper, 2004, Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies, Diabetes/Metabolism Research and Reviews, 20 Suppl 1, S90, 10.1002/dmrr.464 · DOI
  65. Schultz, 2010, CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials, BMJ, 340, c332, 10.1136/bmj.c332 · DOI · Paper page
  66. Schunemann 2011a Schünemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH. Chapter 11: Presenting results 'Summary of findings' tables. In: Higgins JPT Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011. Available from www.cochrane-handbook.org
  67. Schünemann HJ Oxman AD Higgins JPT Deeks JJ Glasziou P Guyatt GH. Chapter 12: Interpreting results drawing conclusions. In: Higgins JPT Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011. Available from www.cochrane-handbook.org
  68. Singh, 2005, Preventing foot ulcers in patients with diabetes, JAMA, 293, 217, 10.1001/jama.293.2.217 · DOI
  69. Skoutas, 2009, Risk factors for ipsilateral reamputation in patients with diabetic foot lesions, The International Journal of Lower Extremity Wounds, 8, 69, 10.1177/1534734609334808 · DOI
  70. Stockl, 2004, Costs of lower-extremity ulcers among patients with diabetes, Diabetes Care, 27, 2129–34, 10.2337/diacare.27.9.2129 · DOI
  71. Stoekenbroek, 2014, Hyperbaric oxygen for the treatment of diabetic foot ulcers: a systematic review, European Journal of Vascular and Endovascular Surgery, 47, 647, 10.1016/j.ejvs.2014.03.005 · DOI
  72. Teng, 2010, Bioengineered skin in diabetic foot ulcers, Diabetes, Obesity & Metabolism, 12, 307, 10.1111/j.1463-1326.2009.01164.x · DOI
  73. Valensi, 2005, Quality of life and clinical correlates in patients with diabetic foot ulcers, Diabetes & Metabolism, 31, 263, 10.1016/S1262-3636(07)70193-3 · DOI
  74. Santema, 2014, Skin grafting and tissue replacement for treating foot ulcers in people with diabetes, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD011255 · DOI

Cited by

See all 38

Metadata

Authors
Santema, T. B., Poyck, P. P., & Ubbink, D. T.
Affiliations
  • Academic Medical Centre at the University of Amsterdam; Department of Surgery; Meibergdreef 9 Room G4-132 Amsterdam Netherlands 1105 AZ
  • Royal Brisbane and Women's Hospital; Department of Vascular Surgery; Butterfield Street Brisbane Herston, Queensland Australia 4029
  • Academic Medical Center at the University of Amsterdam; Department of Surgery; Meibergdreef 9, room G4-184 PO Box 22700 Amsterdam Netherlands 1100 DE
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2016-02-11
Volume
2017
Issue
3
ISSN
1465-1858
DOI
10.1002/14651858.cd011255.pub2
Cited by
38
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Skin grafting and tissue replacement for treating foot ulcers in people with diabetes. https://app.cochat.ai/papers/10.1002/14651858.cd011255.pub2
The paper
Santema, T. B., Poyck, P. P., & Ubbink, D. T. (2016). Skin grafting and tissue replacement for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd011255.pub2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.